Need more options? Click Here for Advanced Search!

Hazardous Waste Pharmaceutical Rule: Important Updates to Your Compliance Obligations Explained - On-Demand

Hazardous Waste Pharmaceutical Rule: Important Updates to Your Compliance Obligations Explained - On-Demand

Product Code: YN6414

Availability: In stock

Internet Special:
$127.00
each
Add Items to Cart

Hazardous Waste Pharmaceutical Rule: Important Updates to Your Compliance Obligations Explained - On-Demand

Webinar now available On-Demand.

The EPA’s proposed Management Standards for the Hazardous Waste Pharmaceuticals Rule, expected to be finalized soon, will impose new mandatory standards for handling pharmaceutical hazardous wastes. The objective of the rule is to “make our drinking and surface water safer and healthier by reducing the amount of pharmaceuticals entering our waterways,” and according to the EPA, this rule will ban healthcare facilities from flushing hazardous waste pharmaceuticals down the sink and toilet. It is projected to prevent the flushing of more than 6,400 tons of hazardous waste every year.

The rule will have a massive impact, as it will affect pharmaceutical reverse distributors and countless healthcare facilities including pharmacies, hospitals, retail pharmacies, clinics, ambulatory surgical centers, chiropractors, mail-order pharmacies, coroners, and medical examiners—the list goes on.

Additionally, the term “pharmaceutical” can be broadly interpreted. The EPA recognizes pharmaceuticals as any chemical or biological product intended for the use in diagnosis, cure, or treatment of a disease in any human or animal. They include dietary supplements, prescription drugs, over-the-counter drugs, container residues and any materials contaminated during spill cleanups.

While not all pharmaceuticals are considered hazardous, a good strategy under the new rule will be to recognize all solid waste pharmaceuticals as hazardous waste pharmaceuticals and manage them as such under the new regulations.

Use this on-demand webinar as Attorney Matthew Wood, Esq., of Gallager & Kennedy, P.A., clarifies the EPA’s rule and offers practical recommendations on how hospitals and all other affected healthcare facilities can adjust their waste management practices to comply with the new rule when it goes into effect.

You’ll learn how to:

  • Identify how existing hazardous waste regulations differ from the proposed rule for managing hazardous waste pharmaceuticals
  • Identify the key elements and requirements of the proposed rule
  • Determine how the proposed rule will apply to your organizations
  • Decide if any of your materials meet the definition of “hazardous waste pharmaceutical” and learn how to manage those wastes
  • Begin to develop a compliance strategy for your organization
  • And more!

About Your Presenter:

Matthew WoodMatthew Wood, Esq. 
Associate 
Gallager & Kennedy, P.A.

Matt Wood graduated from the University of Pittsburgh in 2011 with joint degrees from the School of Law and the Katz Graduate School of Business and has been practicing environmental and natural resource law at Gallagher & Kennedy since 2012.  His practice focuses on environmental remediation, hazardous and toxic substances, hazardous and solid waste issues, and air quality.  He counsels clients throughout various remedial processes and assists clients through compliance counseling, permitting, and other myriad matters.

    Write Your Own Review